News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Slideshows|October 3, 2019

8 examples of how GBCA improves MRI

Author(s)Ilana Cass, MD, Rola Saouaf, MD

Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

ByJustin Drake, PhD

June 4th 2026

Willow announces new breastfeeding accessories to support postpartum care | Image credit: stock.adobe.com

Willow announces new breastfeeding accessories to support postpartum care

ByJoshua Fitch, Senior Editor

March 24th 2026

Aviva to advance, announce new data for AVA-291 women's testosterone therapy | Image credit: Contemporary OB/GYN

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

ByJoshua Fitch, Senior Editor

January 26th 2026

Breastfeeding and later maternal depression and anxiety with Fionnuala McAuliffe

Breastfeeding and later maternal depression and anxiety with Fionnuala McAuliffe

ByFionnuala McAuliffe MD, FRCOG, FRCPI, FSEM, FACOG, FICOG

January 23rd 2026

Low-dose megestrol enhances anti-oestrogen therapy in breast cancer | Image Credit: © NaMong Productions - © NaMong Productions - stock.adobe.com.

Low-dose megestrol enhances anti-oestrogen therapy in breast cancer

ByCeleste Krewson, Assistant Editor

January 12th 2026

Latest CME

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients

Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals

Spotlighting the endometriosis, preeclampsia research gap in Black women, with Calbeth C. Alaribe, DMSc, MPH, PA-C

Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG

A discussion of STI rates, barriers, and home screenings with Damian Alagia III, MD